Exhibit 10.100


 


THIS
NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”).


 


US
$300,000.00


 


BIORESTORATIVE
THERAPIES, INC.


12%
CONVERTIBLE REDEEMABLE NOTE


DUE
NOVEMBER 28, 2019


 


FOR
VALUE RECEIVED, BioRestorative Therapies, Inc. (the “Company”) promises to pay to the order of EAGLE EQUITIES, LLC
and its authorized successors and permitted assigns (“Holder”), the aggregate principal face amount of Three
Hundred Thousand Dollars exactly (U.S. $300,000.00) on November 28, 2019 (“Maturity Date”) and to pay interest
on the principal amount outstanding hereunder at the rate of 12% per annum commencing on November 28, 2018. The interest will
be paid to the Holder in whose name this Note is registered on the records of the Company regarding registration and transfers
of this Note. The principal of, and interest on, this Note are payable at 525 Norton Parkway, New Haven, CT 06511, initially,
and if changed, last appearing on the records of the Company as designated in writing by the Holder hereof from time to time.
The Company will pay each interest payment and the outstanding principal due upon this Note before or on the Maturity Date, less
any amounts required by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to such
Holder at the last address appearing on the records of the Company. The forwarding of such check or wire transfer shall constitute
a payment of outstanding principal hereunder and shall satisfy and discharge the liability for principal on this Note to the extent
of the sum represented by such check or wire transfer. Interest shall be payable in Common Stock (as defined below) pursuant to
paragraph 4(b) herein.


 


This
Note is subject to the following additional provisions:


 


1.
This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested
by the Holder surrendering the same. No ser- vice charge will be made for such registration or transfer or exchange, except that
Holder shall pay any tax or other governmental charges payable in connection therewith.


 


2.
The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable laws.


 




    	 



    	 



    

 


3.
This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended (“Act”)
and applicable state securities laws. Any attempted transfer to a non-qualifying party shall be treated by the Company as void.
Prior to due present- ment for transfer of this Note, the Company and any agent of the Company may treat the person in whose name
this Note is duly registered on the Company’s records as the owner hereof for all other purposes, whether or not this Note
be overdue, and neither the Company nor any such agent shall be affected or bound by notice to the contrary. Any Holder of this
Note electing to exercise the right of conversion set forth in Section 4(a) hereof, in addition to the requirements set forth
in Section 4(a), and any prospective transferee of this Note, also is required to give the Company written confirmation that this
Note is being converted (“Notice of Conversion”) in the form an- nexed hereto as Exhibit A. The date
of receipt (including receipt by telecopy) of such Notice of Conversion shall be the Conversion Date.


 


4.
(a) During the first 6 months this Note is in effect, the Holder of this Note is entitled, at its option, to convert
all or any amount of the principal face amount of this Note then outstanding into shares of the Company’s common stock (the
“Common Stock”) at a price (“Conversion Price”) for each share of Common Stock at fixed
price of $2.00 per share (subject to equitable adjustment for forward and reverse stock splits, stock dividends and the like).
After the 6 monthly anniversary, the Conversion Price shall be equal to the greater of: (i) $0.10 per share (subject to equitable
adjustment as set forth above) (the “Floor Price”) (provided, however, that, in the event that the trading
price of the Common Stock is equal to or less than fifteen cents ($0.15) per share (subject to equitable adjustment as set forth
above) for five (5) consecutive trading days, the Floor Price shall no longer apply), or (ii) 58% of the lowest trading
price of the Common Stock as reported on the National Quotations Bureau OTC Markets exchange which the Com- pany’s
shares are traded or any exchange upon which the Common Stock may be traded in the future (“Exchange”), for
the ten prior trading days including the day upon which a Notice of Con- version is received by the Company
or its transfer agent (provided such Notice of Conversion is delivered by fax or other electronic method of communication to the
Company or its transfer agent after 4 P.M. Eastern Standard or Daylight Savings Time if the Holder wishes to include the same
day closing price). If the shares have not been delivered within 3 business days, the Notice of Conversion may be rescinded. Such
conversion shall be effectuated by the Company delivering the shares of Common Stock to the Holder within 3 business days of receipt
by the Company of the Notice of Conversion. Accrued but unpaid interest shall be subject to conversion. No fractional shares or
scrip representing fractions of shares will be issued on conversion, but the number of shares issuable shall be rounded to the
nearest whole share. To the extent the Conversion Price of the Company’s Common Stock closes below the par value
per share, the Company will take all steps necessary to solicit the consent of the stockholders to reduce the par value to the
lowest value possible under law. The Company agrees to honor all conversions submitted pending this increase. In the event
the Company experiences a DTC “Chill” on its shares, the conversion price shall be decreased to 48% instead of 58%
while that “Chill” is in effect. In no event shall the Holder be allowed to effect a conversion if such conversion,
along with all other shares of Company Common Stock beneficially owned by the Holder and its affiliates would exceed 9.9% of the
outstanding shares of the Common Stock of the Company.


 





 






Initials


 







    	2



    	 



    

 


(b)
Interest on any unpaid principal balance of this Note shall be paid at the rate of 12% per annum. Interest outstanding after the
six month anniversary of this Note, shall be paid by the Company in Common Stock (“Interest Shares”). Holder may,
at any time after the six month anniversary of this Note, send in a Notice of Conversion to the Company for Interest Shares based
on the formula provided in Section 4(a) above. The dollar amount converted into Interest Shares shall be all or a portion of the
accrued interest calculated on the unpaid principal balance of this Note to the date of such notice.


 


(c)
The Notes may be prepaid with the following penalties:


 


	Time
    Period	 	Payment
    Premium
	<=90
    days after note issuance	 	125%
    of the sum of principal plus accrued in- terest
	>90
    days <=180 days after note issuance	 	135%
of the sum of principal plus accrued in-terest



 


This
Note may not be prepaid after the 180th day. Such redemption must be closed and funded within 3 days of giving notice
of redemption of the right to redeem shall be null and void.


 


(d)
Upon (i) a transfer of all or substantially all of the assets of the Company to any person in a single transaction or series of
related transactions, (ii) a reclassification, capital reorganization or other change or exchange of outstanding shares of the
Common Stock, other than a forward or reverse stock split or stock dividend, or (iii) any consolidation or merger of the Com-
pany with or into another person or entity in which the Company is not the surviving entity (other than a merger which is effected
solely to change the jurisdiction of incorporation of the Company and results in a reclassification, conversion or exchange of
outstanding shares of Common Stock solely into shares of Common Stock) (each of items (i), (ii) and (iii) being referred to as
a “Sale Event”), then, in each case, the Company shall, upon request of the Holder, redeem this Note in cash for 150%
of the principal amount, plus accrued but unpaid interest through the date of re- demption, or at the election of the Holder,
such Holder may convert the unpaid principal amount of this Note (together with the amount of accrued but unpaid interest) into
shares of Common Stock immediately prior to such Sale Event at the Conversion Price.


 


(e)
In case of any Sale Event (not to include a sale of all or substantially all of the Company’s assets) in connection with
which this Note is not redeemed or converted, the Com- pany shall cause effective provision to be made so that the Holder of this
Note shall have the right thereafter, by converting this Note, to purchase or convert this Note into the kind and number of shares
of stock or other securities or property (including cash) receivable upon such reclassifica- tion, capital reorganization or other
change, consolidation or merger by a holder of the number of shares of Common Stock that could have been purchased upon exercise
of the Note and at the same Conversion Price, as defined in this Note, immediately prior to such Sale Event. The forego- ing provisions
shall similarly apply to successive Sale Events. If the consideration received by the holders of Common Stock is other than cash,
the value shall be as determined by the Board of Directors of the Company or successor person or entity acting in good faith.


 


5.
No provision of this Note shall alter or impair the obligation of the Com- pany, which is absolute and unconditional, to pay the
principal of, and interest on, this Note at the time, place, and rate, and in the form, herein prescribed.


 





 



Initials


 




    	3



    	 



    

 


6.
The Company hereby expressly waives demand and presentment for pay- ment, notice of non-payment, protest, notice of protest, notice
of dishonor, notice of acceleration or intent to accelerate, and diligence in taking any action to collect amounts called for
hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereto.


 


7.
The Company agrees to pay all costs and expenses, including reasonable attorneys’ fees and expenses, which may be incurred
by the Holder in collecting any amount due under this Note.


 


8.
If one or more of the following described “Events of Default” shall occur:


 


(a)
The Company shall default in the payment of principal or interest on this Note or any other note issued to the Holder by the Company;
or


 


(b)
Any of the representations or warranties made by the Company herein or in any certificate or financial or other written statements
heretofore or hereafter furnished by or on behalf of the Company in connection with the execution and delivery of this Note, or
the Securities Purchase Agreement under which this note was issued shall be false or misleading in any material respect; or


 


(c)
The Company shall fail to perform or observe, in any respect, any material covenant, term, provision, condition, agreement or
obligation of the Company under this Note or any other note issued to the Holder; or


 


(d)
The Company shall (1) become insolvent; (2) make an assignment for the benefit of creditors or commence proceedings for its dissolution;
(3) apply for or consent to the appointment of a trustee, liquidator or receiver for its or for a substantial part of its property
or business; (4) file a petition for bankruptcy relief, consent to the filing of such petition or have filed against it an involuntary
petition for bankruptcy relief, all under federal or state laws as applicable; or


 


(e)
A trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without
its consent and shall not be discharged within sixty (60) days after such appointment; or


 


(f)
Any governmental agency or any court of competent jurisdiction at the in- stance of any governmental agency shall assume custody
or control of the whole or any substantial portion of the properties or assets of the Company; or


 


(g)
One or more money judgments, writs or warrants of attachment, or similar process, in excess of two hundred thousand dollars ($200,000)
in the aggregate, shall be entered or filed against the Company or any of its properties or other assets and shall remain unpaid,
un- vacated, unbonded or unstayed for a period of fifteen (15) days or in any event later than five (5) days prior to the date
of any proposed sale thereunder; or


 


(h)
The Company shall have defaulted on or breached any term of any other note
of similar debt instrument into which the Company has entered and failed to cure such default within the appropriate grace period;
or


 





 






Initials


 



    	4



    	 



    




 


(i)
The Company shall have its Common Stock delisted from an exchange (in- cluding the OTC Market Exchange) or, if the Common
Stock trades on an exchange, then trading in the Common Stock shall be suspended for more than 10 consecutive days or ceases
to file its 1934 act reports with the SEC;


 


(j)
If a majority of the members of the Board of Directors of the Company on the date hereof are no longer serving as members
of the Board;


 


(k)
The Company shall not deliver to the Holder the Common Stock pursuant to paragraph 4 herein without restrictive legend within
3 business days of its receipt of a Notice of Conversion; or


 


(l)
The Company shall not replenish the reserve set forth in Section 12, within 3 business days of the request of the
Holder.


 


(m)
The Company shall not be “current” in its filings with the Securities and Exchange Commission;


 


(n)
The Company shall lose the “bid” price for its stock in a market (including the OTC marketplace or other
exchange); or


 


Then,
or at any time thereafter, unless cured within the time periods set forth herein, and, if not specified, within 5 business days,
and in each and every such case, unless such Event of Default shall have been waived in writing by the Holder (which waiver shall
not be deemed to be a waiver of any subsequent default) at the option of the Holder and in the Holder’s sole discretion,
the Holder may consider this Note immediately due and payable, without presentment, demand, protest or (further) notice of any
kind (other than notice of acceleration), all of which are hereby expressly waived, anything herein or in any note or other instruments
contained to the contrary notwithstand- ing, and the Holder may immediately, and without expiration of any period of grace, enforce
any and all of the Holder’s rights and remedies provided herein or any other rights or remedies afforded by law. Upon an
Event of Default, interest shall accrue at a default interest rate of 18% per annum or, if such rate is usurious or not permitted
by current law, then at the highest rate of interest permitted by law. In the event of a breach of Section 8(k) the penalty shall
be $250 per day the shares are not issued beginning on the 4th day after the conversion notice was delivered to the Company. This
penalty shall increase to $500 per day beginning on the 10th day. Further, if a breach of Section 8(m) occurs or is continuing
after the 6 month anniversary of the Note, then the Holder shall be entitled to use the lowest closing bid price during the delinquency
period as a base price for the conversion. For example, if the lowest closing bid price during the delinquency period is $0.01
per share and the conversion discount is 50% the Holder may elect to convert future con- versions at $0.005 per share.


 


If
the Holder shall commence an action or proceeding to enforce any provisions of this Note, in- cluding, without limitation, engaging
an attorney, then if the Holder prevails in such action, the Holder
shall be reimbursed by the Company for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation
and prosecution of such action or proceeding.


 





 






Initials


 






    	5



    	 



    

 


9.
In case any provision of this Note is held by a court of competent jurisdic- tion to be excessive in scope or otherwise invalid
or unenforceable, such provision shall be ad- justed rather than voided, if possible, so that it is enforceable to the maximum
extent possible, and the validity and enforceability of the remaining provisions of this Note will not in any way be affected
or impaired thereby.


 


10.
Neither this Note nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed
by the Company and the Holder.


 


11.
The Company represents that it is not a “shell” issuer and has never been a “shell” issuer or that if
it previously has been a “shell” issuer that at least 12 months have passed since the Company has reported Form 10
type information indicating it is no longer a “shell issuer. Further, the Company will instruct its counsel to either (i)
write a 144 opinion to allow for salability of the conversion shares or (ii) accept such opinion from Holder’s counsel.


 


12.
The Company shall issue irrevocable transfer agent instructions reserving 205,000 shares of its Common Stock for conversions under
this Note (the “Share Reserve”). Upon full conversion of this Note, any shares remaining in the Share Reserve shall
be cancelled. The Company shall pay all transfer agent costs associated with issuing and delivering the share certif- icates to
Holder. If such amounts are to be paid by the Holder, it may deduct such amounts from the Conversion Price. The company should
at all times reserve a minimum of four times the amount of shares required if the note would be fully converted. The Holder may
reasonably re- quest increases from time to time to reserve such amounts. The Company will instruct its transfer agent to provide
the outstanding share information to the Holder in connection with its conver- sions.


 


13.
The Company will give the Holder direct notice of any corporate actions, including but not limited to name changes, stock splits,
recapitalizations etc. This notice shall be given to the Holder as soon as possible under law. The prices per share set forth
in this Note are subject to adjustment to give effect to any stock splits, reverse stock splits, recapitalizations and the like.


 


14.
If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury,
the applicable provision shall automatically be revised to equal the maximum rate of interest or other amount deemed interest
permitted under applicable law. The Company covenants (to the extent that it may lawfully do so) that it will not seek to claim
or take advantage of any law that would prohibit or forgive the Company from paying all or a portion of the principal or interest
on this Note.


 


15.
This Note shall be governed by and construed in accordance with the laws of New York applicable to contracts made and wholly to
be performed within the State of New York and shall be binding upon the successors and assigns of each party hereto. The Holder
and the Company hereby mutually waive trial by jury and consent to exclusive jurisdiction and venue in
the courts of the State of New York or in the Federal courts sitting in the county or city of New York. This Agreement may be
executed in counterparts, and the facsimile transmission of an executed counterpart to this Agreement shall be effective as an
original.


 


[Remainder
of page intentionally left blank. Signature page follows.]


 





 






Initials


 




    	6



    	 



    

 


IN
WITNESS WHEREOF, the Company has caused this Note to be duly executed by an officer thereunto duly authorized.


 


Dated:
November 28, 2018


 


	 	BIORESTORATIVE
    THERAPIES, INC.
	 	 	 
	 	By:
    	 
	 	Title:	CEO


 





 






Initials


 




    	7



    	 



    

 


EXHIBIT
A


 


NOTICE
OF CONVERSION


 


(To
be Executed by the Registered Holder in order to Convert the Note)


 


The undersigned
hereby irrevocably
elects
to
convert
$                    of
the above Note into                 
Shares of Common Stock of BioRestorative Therapies, Inc. (“Shares”) ac-cording to the conditions set forth
in such Note, as of the date written below.


 


If
Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer and other taxes
and charges payable with respect thereto.


 


	Date
    of Conversion:	 	 
	Applicable
    Conversion Price: 	 	 
	Signature:
    	 	 
		[Print
    Name of Holder and Title of Signer]	 


 


	Address:	 	 
	 	 	 


 


	SSN
    or EIN:	 	 



 


	Shares
    are to be registered in the following name:	 	 


 


	Name:	 	 
	Address:	 	 
	Tel:	 	 
	Fax:	 	 
	SSN
    or EIN:	 	 


 


	Shares are to be sent or delivered to the following account:
	 	 	 
	Account
    Name:	 	 
	Address:	 	 


 





 






Initials


 




    	8